HOB Biotech Group Corp.,Ltd. operates as an in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immune assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. HOB Biotech Group Corp.,Ltd was founded in 2009 and is based in Suzhou, China.
Frequently asked questions
What sector does HOB Biotech Group Corp Ltd (688656) operate in?
HOB Biotech Group Corp Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is HOB Biotech Group Corp Ltd (688656) current stock price?
As of the latest data, HOB Biotech Group Corp Ltd stock price is CN¥132.15, with a previous close of CN¥141.04. HOB Biotech Group Corp Ltd lost -CN¥8.89 in the last trading session, representing a -6.3% loss.
What is HOB Biotech Group Corp Ltd (688656) current market capitalization?
HOB Biotech Group Corp Ltd market cap is approximately 8.39 billion.
What is HOB Biotech Group Corp Ltd (688656) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.45.
What is HOB Biotech Group Corp Ltd (688656) Price-to-Earnings (P/E) ratio?
HOB Biotech Group Corp Ltd current P/E ratio is 293.67.
Does HOB Biotech Group Corp Ltd (688656) pay dividends?
Yes. HOB Biotech Group Corp Ltd pays annual dividends with an annualized yield of 0.15% and an estimated annual payout of CN¥0.20 per share.
When is the next ex-dividend date for HOB Biotech Group Corp Ltd (688656)?
The next ex-dividend date is scheduled for May 29, 2027.
What is HOB Biotech Group Corp Ltd (688656) beta (volatility) score?
HOB Biotech Group Corp Ltd has a beta of -0.275, indicating lower volatility than the overall market.
